Stephens Downgrades Mednax (MD) to Equal Weight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Deutsche Bank Upgrades Mednax (MD) to Hold after Solid Q3
November 2, 2012 6:57 AM EDTDeutsche Bank upgraded Mednax (NYSE: MD) from Sell to Hold with a price target of $76.00 (from $65.00) following Q3 results.
The firm comments, "MD's last two quarters have significantly allayed our concerns about a steeper slow-down in NICU trends. The combination of... More
Mednax (MD) Tops Q3 EPS by 4c, Guides Q4 In Line
November 1, 2012 7:24 AM EDTMednax (NYSE: MD) reported Q3 EPS of $1.32, $0.04 better than the analyst estimate of $1.28. Revenue for the quarter came in at $473.1 million versus the consensus estimate of $470.6 million.
Mednax sees Q4 2012 EPS of $1.27-1.32, versus the consensus of $1.29.
For earnings history and earnings-related data on Mednax (MD) click here.... More
